Ribavirin and Interferon alfa-2b, recomb... News Headlines

• Human Genome Sciences Initiates Phase 3 Clinical Trial Of Albuferon(R) With Ribavirin In Patients With Chronic Hepatitis C Genotypes 2 And 3
  MedicalNewsToday - Wed, 28 Feb 2007 08:00 EST
  
• The Market Of Recombinant Coagulation Factors Is Growing With Next Generation Products
  MedicalNewsToday - Thu, 15 Feb 2007 08:00 EST
  
• NanoBio(R) Corporation Initiates Phase 2b Clinical Trial For Herpes Labialis Treatment
  MedicalNewsToday - Fri, 16 Feb 2007 08:00 EST
  
• New Data On Investigational Agent TMC278 In Anitretroviral-Naive HIV Patients
  MedicalNewsToday - Fri, 02 Mar 2007 08:00 EST
  
• InterMune Discontinues Phase 3 INSPIRE Trial Of Actimmune In Idiopathic Pulmonary Fibrosis
  MedicalNewsToday - Tue, 06 Mar 2007 08:00 EST
  
• FDA Clears First Of Its Kind Suture Made Using DNA Technology
  MedicalNewsToday - Thu, 15 Feb 2007 08:00 EST
  
• First Recombinant DNA-Based Suture Approved
  MedicineNet - Wed, 14 Feb 2007 07:00 EST
  
• Fed. Of American Hospitals Proposes Nationwide Health Insurance Mandate That Would Add $115.2B Annually To Current Federal, State Health Care Spending
  MedicalNewsToday - Mon, 26 Feb 2007 09:00 EST
  
• Metabasis Announces Completion Of Enrollment In The Phase 2b Clinical Trial For CS-917 In Patients With Type 2 Diabetes
  MedicalNewsToday - Fri, 02 Feb 2007 08:00 EST
  
• Genelabs Announces Publication In New England Journal Of Medicine Of Clinical Trial Results With Hepatitis E Virus Vaccine
  MedicalNewsToday - Fri, 02 Mar 2007 08:00 EST
  
• Copegus Approved In Japan As Combination Therapy With Pegasys For Patients With Chronic Hepatitis C
  MedicalNewsToday - Mon, 29 Jan 2007 08:00 EST
  
• Lilly Plans New Clinical Trial Of Xigris(R)
  MedicalNewsToday - Tue, 27 Feb 2007 08:00 EST
  
• Bioengineering Efficient Antibiotic Biosynthesis In E. Coli
  ScienceDaily - Wed, 21 Feb 2007 04:00 EST
  
• ZymoGenetics Begins Clinical Trial For PEG-Interferon Lambda As Potential Treatment For Viral Infection
  MedicalNewsToday - Wed, 31 Jan 2007 08:00 EST
  
• Biolex Therapeutics Announces Initiation Of Locteron(TM) Phase 2 Clinical Study In Chronic Hepatitis C
  MedicalNewsToday - Wed, 31 Jan 2007 08:00 EST
  
• Leading Advocates Against Genetically Modified RBGH Milk File Citizen's Petition With FDA
  MedicalNewsToday - Thu, 22 Feb 2007 08:00 EST
  
• Spectrum Pharmaceuticals Initiates Phase 2b Trial For Ozarelix In Patients With Benign Prostate Hypertrophy
  MedicalNewsToday - Fri, 26 Jan 2007 08:00 EST
  
• Dainippon Sumitomo Pharma Announces Launch Of "Replagal(R) 3.5 Mg" For Anderson-Fabry Disease
  MedicalNewsToday - Sun, 18 Feb 2007 08:00 EST
  
• Human Genome Sciences Initiates Phase 3 Clinical Trial Of Albuferon(R) In Combination With Ribavirin For Patients With Chronic Hepatitis C
  MedicalNewsToday - Wed, 20 Dec 2006 08:00 EST
  
• EU-Approval For Continuous Infusion Of KOGENATE® Bayer
  MedicalNewsToday - Mon, 12 Feb 2007 08:00 EST
  
• Viragen Reports OVA(TM) System Milestone: Interferon Alpha Expressed In Eggs
  MedicalNewsToday - Thu, 25 Jan 2007 08:00 EST
  
• New York Gov. Spitzer Proposes $1.2B In Cuts To Health Care Programs, Expansion Of Children's Health Insurance Program
  MedicalNewsToday - Tue, 06 Feb 2007 01:00 EST
  
• Aida Pharmaceuticals' Researchers Publish Academic Article On Phase I Results Of Rh-Apo2L In Top Chinese Scholarly Journal
  MedicalNewsToday - Thu, 08 Feb 2007 08:00 EST
  
• Interferon-Treated Hepatitis C Patients Likely To Experience Retinopathy
  MedicalNewsToday - Sat, 06 Jan 2007 05:00 EST
  
• UnitedHealth Reports Q4 Earnings Of $1.2B, Enrollment Increase In Medicare Prescription Drug Plan
  MedicalNewsToday - Wed, 24 Jan 2007 01:00 EST
  
• Spectrum Pharmaceuticals Announces FDA's Acceptance Of Ozarelix IND And Approval Of Phase 2b Protocol In BPH (Benign Prostate Hypertrophy)
  MedicalNewsToday - Fri, 05 Jan 2007 08:00 EST
  
• Halozyme Therapeutics Releases Results Of Enhanze Technology Clinical Trial
  MedicalNewsToday - Tue, 23 Jan 2007 08:00 EST
  
• New Edition Of Landmark Textbook Incorporates Contemporary Genome-Based View Of Biology
  MedicalNewsToday - Sun, 07 Jan 2007 05:00 EST
  
• Allergic Reactions To Insulin Have Declined And CSII Could Reduce Them Further
  ScienceDaily - Thu, 11 Jan 2007 04:00 EST
  
• Human Genome Sciences Reports Positive Interim Results Of Phase 2 Trials Of Albuferon(TM) With Ribavirin In Patients With Chronic Hepatitis C
  MedicalNewsToday - Wed, 01 Nov 2006 08:00 EST
  
• Allergic Reactions To Insulin Have Declined And CSII Could Reduce Them Further
  MedicalNewsToday - Wed, 10 Jan 2007 11:00 EST
  
• HCV patients may develop retinopathy
  The Earth Times - Thu, 04 Jan 2007 03:20 EST
  
• Nuvelo Initiates Phase 2 Trial Of RNAPc2 In Patients With Metastatic Colorectal Cancer
  MedicalNewsToday - Sat, 06 Jan 2007 08:00 EST
  
• Interim Analysis Of Phase III Trial Shows Avastin Plus Interferon Therapy In Patients With Previously Untreated Advanced Renal Cell Carcinoma
  MedicalNewsToday - Mon, 25 Dec 2006 08:00 EST
  
• Amgen Responds To Reports About Use And Safety Of EPOGEN And Aranesp In CKD Anemia Therapy
  MedicalNewsToday - Mon, 11 Dec 2006 08:00 EST
  
• Vertex Pharmaceuticals Announces Results Of First Interim Safety And Antiviral Analysis Of The PROVE 1 Clinical Trial For Hepatitis
  MedicalNewsToday - Sun, 24 Dec 2006 08:00 EST
  
• Majority Of Cancer-Related Anemia Patients Treated With PROCRIT(R) (Epoetin Alfa) Once Every Three Weeks Achieved Target Hemoglobin
  MedicalNewsToday - Sat, 09 Dec 2006 08:00 EST
  
• ZymoGenetics Submits Biologics License Application To The FDA For RhThrombin As An Aid To Controlling Bleeding During Surgery
  MedicalNewsToday - Tue, 19 Dec 2006 08:00 EST
  
• Decreased Bleeding Frequency With Secondary Prophylactic Use Of NovoSeven (REG) Shown
  MedicalNewsToday - Thu, 14 Dec 2006 03:00 EST
  
• Assisted Living Compensation Report Released - First Ever Details On Salaries, From Front-line To Corner Office
  MedicalNewsToday - Fri, 01 Dec 2006 08:00 EST
  
• Palatin Technologies Presents At The 9th European Society For Sexual Medicine (ESSM) Congress
  MedicalNewsToday - Wed, 06 Dec 2006 08:00 EST
  
• New Phase 2 Data Show Promise Of Aranesp(R) Treatment For Anemia Of Cancer
  MedicalNewsToday - Mon, 11 Dec 2006 08:00 EST
  
• Natural, Soy-based Substance Might Help Fight Multiple Sclerosis, Neuroscientists Find
  ScienceDaily - Tue, 12 Dec 2006 04:00 EST
  
• Palatin Technologies And King Pharmaceuticals Report Results For Two Phase 2B Clinical Trials Evaluating Bremelanotide
  MedicalNewsToday - Tue, 07 Nov 2006 08:00 EST
  
• Majority Of Anemic Chronic Kidney Disease Pre-Dialysis Patients Achieved Target Hemoglobin Range With PROCRIT® (Epoetin Alfa)
  MedicalNewsToday - Thu, 23 Nov 2006 08:00 EST
  
• Final Phase 2 Data Continue To Show Promising Results After One Year Of Aranesp(R) Treatment For Anemia In Patients With Myelodysplastic Syndromes
  MedicalNewsToday - Mon, 11 Dec 2006 08:00 EST
  
• Phase II Trial Of Interferon In Combination With Thalidomide For Metastatic Renal Cell Carcinoma
  MedicalNewsToday - Wed, 22 Nov 2006 08:00 EST
  
• Anacor Begins Phase 2b Study Of AN0128 In Children
  MedicalNewsToday - Fri, 10 Nov 2006 08:00 EST
  
• Making Headway Against Hepatitis C: New Drug Combo Effective In Non-Responders
  MedicalNewsToday - Thu, 02 Nov 2006 08:00 EST
  
• Majority Of Anemic Chronic Kidney Disease Pre-Dialysis Patients Achieved Target Hemoglobin Range With PROCRIT(R) (Epoetin Alfa) Therapy
  MedicalNewsToday - Mon, 20 Nov 2006 08:00 EST
  
• Maxygen's Next-Generation Interferon Alpha Enters Phase Ia Clinical Trial
  MedicalNewsToday - Wed, 08 Nov 2006 08:00 EST
  
• Betaferon(R) Approved In Australia For Earliest Stages Of Multiple Sclerosis
  MedicalNewsToday - Fri, 24 Nov 2006 08:00 EST
  
• Merck Launches National Advertising Campaign For GARDASIL®, Merck's New Cervical Cancer Vaccine
  MedicalNewsToday - Thu, 23 Nov 2006 08:00 EST
  
• District Court Judge Denies Preliminary Injunction In Ortho V. Amgen Suit
  MedicalNewsToday - Thu, 23 Nov 2006 08:00 EST
  
• Avonex®, The Most Prescribed Multiple Sclerosis Therapy Worldwide, Launched In Japan
  MedicalNewsToday - Thu, 23 Nov 2006 08:00 EST
  
• Is Blood Coagulating Drug Dangerous For Troops Or A Life Saver?
  MedicalNewsToday - Sun, 19 Nov 2006 08:00 EST
  
• Merck's Cervical Cancer Vaccine, Gardasil®, Added To The Cdc Vaccines For Children Contract
  MedicalNewsToday - Fri, 03 Nov 2006 08:00 EST
  
• VIVUS Announces Results Of ALISTA Phase 2b Study
  MedicalNewsToday - Sat, 30 Sep 2006 07:00 EST
  
• New TB Testing Regime A Step Forward, But Not A Solution On Its Own, National Farmers' Union, UK
  MedicalNewsToday - Sat, 28 Oct 2006 07:00 EST
  
• Interferon benefits early multiple sclerosis
  Reuters - Thu, 05 Oct 2006 02:14 EST
  
• Amgen Receives Complete Response Letter For Extended Dosing Of Aranesp(R) For Patients With Chronic Kidney Disease And Anemia
  MedicalNewsToday - Sun, 15 Oct 2006 07:00 EST
  
• OrthoLogic Announces Results Of Preliminary Interim Analysis Of Phase 2b Clinical Trial Of Chrysalin(R) (TP508) In Fracture Repair
  MedicalNewsToday - Wed, 30 Aug 2006 07:00 EST
  
• Advate's Safety Profile Confirmed For Haemophilia Therapy
  MedicalNewsToday - Mon, 21 Aug 2006 07:00 EST
  
• European Commission Approves GARDASIL®, Merck's Cervical Cancer Vaccine
  MedicalNewsToday - Mon, 25 Sep 2006 07:00 EST
  
• Study Shows Patient Preference For Gonal-f(R) RFF Pen To Treat Infertility
  MedicalNewsToday - Tue, 26 Sep 2006 07:00 EST
  
• Hepatitis C Recurrence After Liver Transplantation
  MedicalNewsToday - Tue, 11 Jul 2006 01:00 EST
  
• Emisphere's Eligen(R) Technology Demonstrates Delivery Of Active Recombinant Human Growth Hormone
  MedicalNewsToday - Wed, 06 Sep 2006 07:00 EST
  
• African Americans Have Lower Response Rate To Standard Therapy For Hepatitis C
  MedicalNewsToday - Sat, 19 Aug 2006 10:00 EST
  
• Trying To Improve On Activity Of Interferon-Alpha In Metastatic Renal Cell Carcinoma: Interferon Plus Cimetidine In A Phase III Randomized Trial
  MedicalNewsToday - Mon, 21 Aug 2006 07:00 EST
  
• Synta Pharmaceuticals Announces Phase 2 Trial Data Showing STA-4783 Doubles Median Progression-Free Survival In Metastatic Melanoma
  MedicalNewsToday - Tue, 12 Sep 2006 07:00 EST
  
• Genzyme Reports Interim Results From Trial Of Campath(R) For Multiple Sclerosis
  MedicalNewsToday - Fri, 15 Sep 2006 07:00 EST
  
• Amgen Launches Aranesp Prefilled Sureclick™ Autoinjector For Treatment Of Anemia
  MedicalNewsToday - Sun, 10 Sep 2006 11:00 EST
  
• New Autoinjector Offers Secure And Simple Way To Administer Anemia Treatment Associated With Chemotherapy And Chronic Kidney Disease
  MedicalNewsToday - Sun, 10 Sep 2006 07:00 EST
  
• Risk Of Developing Multiple Sclerosis Significantly Reduced With Interferon Beta-1b Early Treatment
  MedicalNewsToday - Fri, 18 Aug 2006 07:00 EST
  
• Interferon Gamma Therapy May Be An Important Advance In Idiopathic Pulmonary Fibrosis Patients
  MedicalNewsToday - Wed, 30 Aug 2006 07:00 EST
  
• ViroPharma Announces Positive Data From Phase 1b Combination Study Of HCV-796 And Pegylated Interferon In Hepatitis C Patients
  MedicalNewsToday - Tue, 29 Aug 2006 07:00 EST
  
• Statins Stop Hepatitis C Virus From Replicating
  ScienceDaily - Sun, 09 Jul 2006 02:00 EST
  
• ViroPharma And Wyeth Announce Achievement Of Proof Of Concept Milestone For HCV-796
  MedicalNewsToday - Tue, 15 Aug 2006 07:00 EST
  
• Interferon-gamma Keeps Over-aggressive Immune Responses In Check
  MedicalNewsToday - Mon, 14 Aug 2006 01:00 EST
  
• Hepatitis C Virus Stopped From Replicating By Statins
  MedicalNewsToday - Mon, 10 Jul 2006 09:00 EST
  
• New Cattle TB Testing Regime Is Step Forward But No Solution, UK
  MedicalNewsToday - Sat, 12 Aug 2006 04:00 EST
  
• Prospective Study Examines Combination Of Intralesional Interferon-Alpha 2b And Oral Vitamin E For Treatment Of Early Stage Peyronie's Disease
  MedicalNewsToday - Tue, 11 Jul 2006 06:00 EST
  
• BVA Welcomes Further Action To Improve Testing Of Cattle For Bovine TB, UK
  MedicalNewsToday - Sat, 12 Aug 2006 08:00 EST
  
• Halozyme Therapeutics Announces New Studies From HTI-101 Presented At Proteoglycan Research Conference
  MedicalNewsToday - Sat, 15 Jul 2006 06:00 EST
  
• Phase 2 Clinical Trial For Plague Vaccine Candidate RF1V
  MedicalNewsToday - Sat, 15 Jul 2006 06:00 EST
  
• ASCO 2006 - Plenary Session: Renal Cell Cancer
  MedicalNewsToday - Sun, 11 Jun 2006 11:00 EST
  
• Heat-shock Protein Vaccine Reduces Alveolar Bone Loss
  MedicalNewsToday - Tue, 04 Jul 2006 12:00 EST
  
• European Medicines Agency Adopts First Positive Opinion For A Medicinal Product Derived From Transgenic Biotechnology
  MedicalNewsToday - Mon, 05 Jun 2006 02:00 EST
  
• Veterans Affairs, Louisiana Announce $1.2B Hospital Complex For New Orleans
  MedicalNewsToday - Fri, 23 Jun 2006 11:00 EST
  
• Senate Committee Approves Agriculture Appropriations Bill, Including $18.2B For FDA, USDA
  MedicalNewsToday - Tue, 27 Jun 2006 02:00 EST
  
• Mount Sinai School Of Medicine Licenses Avian Flu Vaccine To Avimex
  MedicalNewsToday - Tue, 27 Jun 2006 03:00 EST
  
• Aranesp May Lower Hospitalization Risk And All-Cause Mortality In Heart Failure Patients With Anemia, Based On A Prespecified Pooled Analysis
  MedicalNewsToday - Mon, 26 Jun 2006 06:00 EST
  
• Octagenarians With Superficial Bladder Cancer Exhibit A Decreased Response To Intravesical Immunotherapy
  MedicalNewsToday - Mon, 19 Jun 2006 06:00 EST
  
• The Basics: In Drug Tests, Enhancements Are Needed
  New York Times - Sun, 11 Jun 2006 03:00 EST
  
• ZymoGenetics Completes Enrollment For RhThrombin Phase 3 Trial
  MedicalNewsToday - Wed, 21 Jun 2006 06:00 EST
  
• Study Explores Use Of PROCRIT(R) (Epoetin Alfa) Once Every Two Weeks As Initiation Treatment For Chemotherapy-Related Anemia
  MedicalNewsToday - Sun, 04 Jun 2006 06:00 EST
  
• Study Of Aranesp(R) Dosed Every Two Weeks Versus Epoetin Alfa Dosed Weekly
  MedicalNewsToday - Mon, 22 May 2006 06:00 EST
  
• Hepatitis C Patients Benefit From Combination Of VX-950 And Pegylated Interferon
  MedicalNewsToday - Tue, 02 May 2006 06:00 EST
  
• Update On Oral HCV Protease Inhibitor SCH 503034 Clinical Development Program For Hepatitis C
  MedicalNewsToday - Wed, 26 Apr 2006 06:00 EST
  
• Nuvelo Announces Completion Of Phase 2 Heparin Replacement Trial Evaluating RNAPc2 In Acute Coronary Syndromes
  MedicalNewsToday - Fri, 02 Jun 2006 06:00 EST